These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 9003332)

  • 21. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of chemoreduction on retinoblastoma-induced retinal detachment.
    Shields CL; Shields JA; DePotter P; Himelstein BP; Meadows AT
    J Pediatr Ophthalmol Strabismus; 1997; 34(3):165-9. PubMed ID: 9168421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of induction chemotherapy in retinoblastoma, alone or combined with other adjuvant modalities.
    Ghose S; Nizamuddin SH; Sethi A; Mohanti BK; Kumar H; Arya LS; Thavaraj V
    J Pediatr Ophthalmol Strabismus; 2002; 39(3):143-50. PubMed ID: 12051279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results.
    Levy C; Doz F; Quintana E; Pacquement H; Michon J; Schlienger P; Validire P; Asselain B; Desjardins L; Zucker JM
    Br J Ophthalmol; 1998 Oct; 82(10):1154-8. PubMed ID: 9924303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment with ranimustine and carboplatin for recurrent intraocular retinoblastoma with vitreous seeding.
    Ishii E; Matsuzaki A; Ohnishi Y; Kai T; Ueda K
    Am J Clin Oncol; 1996 Dec; 19(6):562-5. PubMed ID: 8931671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
    Kim JW; Yau JW; Moshfeghi D; Fishman M
    J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative treatments of intraocular retinoblastoma.
    Lumbroso-Le Rouic L; Aerts I; Lévy-Gabriel C; Dendale R; Sastre X; Esteve M; Asselain B; Bours D; Doz F; Desjardins L
    Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservative therapy in intraocular retinoblastoma: response/recurrence rate.
    Schiavetti A; Hadjistilianou T; Clerico A; Bonci E; Ragni G; Castello MA
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):3-6. PubMed ID: 15654270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
    Fabian ID; Stacey AW; Johnson KP; Onadim Z; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
    Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
    Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
    Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of primarily treated group D retinoblastoma.
    Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
    Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
    J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.
    Doz F; Neuenschwander S; Plantaz D; Courbon B; Gentet JC; Bouffet E; Mosseri V; Vannier JP; Mechinaud F; Desjardins L
    J Clin Oncol; 1995 Apr; 13(4):902-9. PubMed ID: 7707117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).
    Jubran RF; Villablanca JG; Krailo M; Piao J; Huang L; Murphree AL; O'Brien J; Gombos D; Shields CL; Meadows A; Chintagumpala M
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28502. PubMed ID: 32589362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM; Kingston J; Hungerford JL
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.